This content is only available within our institutional offering.

15 Aug 2023
Hikma Pharmaceuticals (HIK LN, 2,480p, Buy) (Upgrade) - Lifted Generics forecasts – FY23E EBITA +4%, target price upgrade

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (HIK LN, 2,480p, Buy) (Upgrade) - Lifted Generics forecasts – FY23E EBITA +4%, target price upgrade
Hikma Pharmaceuticals Plc (HIK:LON) | 1,828 -676.4 (-2.0%) | Mkt Cap: 4,056m
- Published:
15 Aug 2023 -
Author:
Miles Dixon -
Pages:
14 -